Randy H. Thurman's most recent trade in Tff Pharmaceuticals Inc was a trade of 34,504 Common Stock done at an average price of $15.9 . Disclosure was reported to the exchange on Nov. 11, 2020.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tff Pharmaceuticals Inc | Randy H. Thurman | Director | Sale of securities on an exchange or to another person at price $ 15.91 per share. | 11 Nov 2020 | 34,504 | 5,000 (0%) | 0% | 15.9 | 548,890 | Common Stock |
| Tff Pharmaceuticals Inc | Randy H. Thurman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2020 | 34,504 | 124,925 | - | - | Stock Options (Right to Buy) | |
| Tff Pharmaceuticals Inc | Randy H. Thurman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share. | 11 Nov 2020 | 34,504 | 39,504 (0%) | 0% | 2.5 | 86,260 | Common Stock |
| Tff Pharmaceuticals Inc | Randy H. Thurman | Director | Sale of securities on an exchange or to another person at price $ 17.17 per share. | 11 Nov 2020 | 5,000 | 0 (0%) | 0% | 17.2 | 85,865 | Common Stock |
| Outlook Therapeutics Inc | Randy H. Thurman | Director | Purchase of securities on an exchange or from another person at price $ 0.62 per share. | 14 Sep 2020 | 10,000 | 11,875 (0%) | 0% | 0.6 | 6,200 | Common Stock |